Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Mikhail Khodorkovsky: Who Wants To Capture Russia? Catsplained.
    Mikhail Khodorkovsky: Who Wants To Capture Russia? Catsplained. World News
  • Electric Vehicle (EV) Battery Cell and Pack Materials Market 2025: Growth, Trends, and Forecast
    Electric Vehicle (EV) Battery Cell and Pack Materials Market 2025: Growth, Trends, and Forecast World News
  • Debbie Wingham explores luxury shoes and ad tech on “The Most Expensive” new episode
    Debbie Wingham explores luxury shoes and ad tech on “The Most Expensive” new episode World News
  • PenFactory to Celebrate International Women’s Day With 15% Off Sitewide
    PenFactory to Celebrate International Women’s Day With 15% Off Sitewide Business
  • FAA Drone Safety Day Quickly Approaching
    FAA Drone Safety Day Quickly Approaching Aviation
  • Day 357: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    Day 357: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Classical Music Podcasts Produced in New Hampshire Reach Audiences Around the World
    Classical Music Podcasts Produced in New Hampshire Reach Audiences Around the World World News
  • Virtual Reality In Education Global Market Estimated To Grow At 36% Rate
    Virtual Reality In Education Global Market Estimated To Grow At 36% Rate World News
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients

Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients

Posted on November 1, 2022 By NewsEditor
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis IngredientsGb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis IngredientsAs published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm's sponsored research used co-cultured human, primary immune cells as a model to evaluate the ability of selected Cannabis constituents to decrease inflammation.

Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
Gb Sciences


LAS VEGAS - November 1, 2022 - (Newswire.com)

Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the journal Food and Chemical Toxicology that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation. Finding Cannabis compounds with anti-inflammatory properties may be useful in decreasing inflammation associated with a wide range of serious human disorders, and these Cannabis compounds potentially have more favorable side effect profiles than NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), which currently lead the anti-inflammatory market based on sales. Largely because of the increasing prevalence of chronic and auto-immune inflammatory disorders, the market for anti-inflammatory therapies is expected to grow to $191.42 billion by 2027.

"We believe that this is the first demonstration of the anti-inflammatory potential of some very potent minor cannabinoids and terpenes derived from Cannabis," said Dr. Andrea Small-Howard, President, Chief Science Officer, and Director of Gb Sciences. "The identification of cell type-specific immune modulating effects by different individual cannabinoids and terpenes was an important first step in designing our novel anti-inflammatory therapies. The results from our second study on the anti-inflammatory effects of proprietary mixtures of these ingredients will be published subsequently with our collaborators at Michigan State University and Chaminade University."

Gb Sciences selected the specific Cannabis constituents for this study based on their prior activity within chemovar studies. To determine whether these cannabinoids and terpenes could reduce inflammation, Gb Sciences' colleagues at Michigan State University tested the individual Cannabis constituents over a wide range of concentrations in human, primary immune cells in a co-culture system that mimics the complex interactions that regulate the human immune system. Three immune cell types were chosen as representatives within these native human immune cell mixtures based on their important roles in modulating the inflammatory cascade.

This study demonstrated that delta-9 tetrahydrocannabinol (THC) had the greatest effect on reducing inflammatory biomarkers and processes in all three immune cell types. Following THC, the greatest immune activity modulation was measured by cannabidivarin (CBDV), cannabigerol (CBG), cannabichromene (CBC), cannabinol (CBN), and lastly, cannabidiol (CBD) in decreasing order based on the number of statistically significant changes measured in inflammatory bioassays relative to the control. Some of these minor cannabinoids and the terpenes tested had very 'selective' anti-inflammatory effects, which targeted a single cell type and/or caused a change in only a single inflammatory bioassay.

This study entitled "Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa employing human primary leukocytes" was co-authored by Gb Sciences' own President and Chief Science Officer, Andrea Small-Howard, and her collaborators Lance K. Blevins, Anthony P. Bach, Robert B. Crawford, Jiajun Zhou, Joseph E. Henriquez, Michael D. Rizzo, Sera Sermet, D.M. Isha Olive Khan, and Norbert Kaminski from Michigan State University (East Lansing, Michigan, USA) and Helen Turner from Chaminade University of Honolulu (Honolulu, Hawai'i, USA). The second part of this study measured the effects of proprietary mixtures of cannabinoids and terpenes on inflammation within this human, primary immune cell model, and this second study will be published next in collaboration with our colleagues at Michigan State University and Chaminade University.

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six issued U.S. and three issued foreign patents, as well as 17 U.S. and 51 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety, and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada. The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome related to COVID-19, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.


Contact Information:
Madeleine Moench
[email protected]


Press Release Service by Newswire.com

Original Source: Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
Business

Post navigation

Previous Post: New CDMO Client, Quality Chemical Laboratories, Benefits From InstantGMP’s All-in-One Quality & Manufacturing System and Software Auditing for GMP Manufacturers
Next Post: Infillion Appoints Margaret Chu as CFO

Related Posts

  • Facilities Advisors Announces Maintenance Planning for Timeshare Resorts
    Facilities Advisors Announces Maintenance Planning for Timeshare Resorts Business
  • Lucata Corporation Announces Frank Brown as Chief Financial Officer
    Lucata Corporation Announces Frank Brown as Chief Financial Officer Business
  • Next Generation Sequencing Market Projected to Reach Valuation of USD 97.8 Billion at 18.3% CAGR from 2024-2035
    Next Generation Sequencing Market Projected to Reach Valuation of USD 97.8 Billion at 18.3% CAGR from 2024-2035 Business
  • Second Alpha Raises Oversubscribed 0 Million Fund V
    Second Alpha Raises Oversubscribed $170 Million Fund V Business
  • A Retrospective Paintings Exhibition of the Song Dynasty on the occasion of the UN Chinese Language Day
    A Retrospective Paintings Exhibition of the Song Dynasty on the occasion of the UN Chinese Language Day Business
  • Juan Carlos Samaniego Achieves Amazon Best-Seller Status with “Never Give Up,” Co-Authored with Dick Vitale
    Juan Carlos Samaniego Achieves Amazon Best-Seller Status with “Never Give Up,” Co-Authored with Dick Vitale Business
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« May    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Market Share, Segments, and Emerging TrendsJune 23, 2025
  • IMPORTANT NOTICE TO ARMADA WASTE MANAGEMENT/GPB WASTE MANAGEMENT INVESTORS WHO SUFFERED LOSSESJune 23, 2025
  • R2 Recycling Expands E-Waste Pickup Services for Businesses & SchoolsJune 23, 2025
  • IMPORTANT NOTICE TO GPB NYC DEVELOPMENT INVESTORS WHO SUFFERED LOSSESJune 22, 2025
  • Alexander Döll Appointed CEO of the Methanol InstituteJune 22, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Tuxera to Showcase Fusion File Share SMB Server at SC22
    Tuxera to Showcase Fusion File Share SMB Server at SC22 Business
  • Lymphedema Market is Projected to Grow at a CAGR of 7.6% from 2023-2033
    Lymphedema Market is Projected to Grow at a CAGR of 7.6% from 2023-2033 Business
  • Southwestern Scale Announces Expansion Into Colorado
    Southwestern Scale Announces Expansion Into Colorado Business
  • Investment strategies for housing stocks
    Investment strategies for housing stocks World News
  • The World’s Largest Premium Cannabis Clone Nursery
    The World’s Largest Premium Cannabis Clone Nursery Business
  • Prime Insurance Company Hosts and Mentors X School Students
    Prime Insurance Company Hosts and Mentors X School Students Business
  • THEVOZ & Partners Expands to Honolulu, Welcoming Stephen M. Tannenbaum as New Partner
    THEVOZ & Partners Expands to Honolulu, Welcoming Stephen M. Tannenbaum as New Partner Business
  • Former Montana Secretary of State Corey Stapleton Says ‘Pay It Forward’, Announces Bid for U.S. President 2024
    Former Montana Secretary of State Corey Stapleton Says ‘Pay It Forward’, Announces Bid for U.S. President 2024 World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .